Brief: Epigenomics Q1 Net Loss Increased To EUR 3.2 Mln
09/05/2018 07:21
May 9 (Reuters) - EPIGENOMICS AG ECXn.DE :
* ANNOUNCES 2018 FIRST QUARTER FINANCIAL RESULTS
* Q1 TOTAL REVENUE SLIGHTLY INCREASED TO EUR 309 THOUSAND
(Q1
2017: EUR 281 THOUSAND)
* Q1 OPERATING LOSS (EBIT) INCREASED TO EUR 3.3 MILLION (Q1
2017:
EUR 2.7 MILLION)
* Q1 NET LOSS INCREASED TO EUR 3.2 MILLION (Q1 2017: EUR 2.4
MILLION)
* OUTLOOK 2018 CONFIRMED
Source text for Eikon: ID:nEQ30YnDha
Further company coverage: ECXn.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns